Futura Medical Share News (FUM)

European Wealth Appoints Jonathan Freeman As Non-Executive Director

LONDON (Alliance News) - European Wealth Group Ltd said Monday it appointed Jonathan Freeman as non-executive director.Freeman currently holds the roles of non-executive chairman of LED of

Futura Says Licensing Of Erectile Dysfunction Gel Remains Top Priority

LONDON (Alliance News) - Futura Medical PLC Chairman John Clarke said Wednesday the company continues to make "good progress" both in product development and commercialisation.In

Futura Medical Begins Groundwork For MED 2002 Phase III Trial

LONDON (Alliance News) - Healthcare firm Futura Medical PLC said Thursday it has started preparing for a phase III trial for its proposed erectile dysfunction gel MED 2002.This trial what a

Futura Medical Annual Loss Widens On Higher Research Costs

LONDON (Alliance News) - Futura Medical PLC said Wednesday that planned increase in research and development expenditure for the development of erectile dysfunction gel has in

Futura Medical signs license agreement with Thornton & Ross

(ShareCast News) - Futura Medical, an AIM listed innovative healthcare company focused on transdermal technology, has signed a licensing agreement with Thornton & Ross for the commercialisation of TPR100, the company's novel diclofenac gel for pain relief. Thornton & Ross (T&R) is one of the largest

Futura To Develop Two Dose Strengths Of Erectile Dysfunction Gel

Futura Medical partner approved for erectogenic condom manufacture

(ShareCast News) - Advanced transdermal technology-focused healthcare company Futura Medical announced on Thursday that, as anticipated, its regulatory submission to allow TTK Protective Devices to manufacture its erectogenic condom, CSD500, has been approved by the relevant EU Notified Body with an

Futura Medical To Raise Up To GBP12 Million To Speed Up Products (ALLISS)

Futura Medical perks up on 'breakthrough' erectile dysfunction study

(ShareCast News) - Shares in AIM-listed Futura Medical perked up to a two-year high as the company revealed that trials of its erectile dysfunction (ED) treatment had found it to be effective, safe and with the potential to be the fastest-acting product on the market. A clinical study of Futura's ME

LONDON BRIEFING: Change At Top For Well-Performing Hargreaves Lansdown

Futura Medical Gets Positive Results On Erectile Dysfunction Gel

Futura Medical Sees "Clear Potential For Value Generation This Year"

Futura Medical Signs Southeast Europe Distribution Deal For Condom

Futura Signs Manufacturing And Indian Distribution Deal For New Condom